OKLO vs. VRNA

Last updated Jun 13, 2026

OKLO (Oklo Inc.) and VRNA (Verona Pharma plc) are both stocks. OKLO operates in Utilities - Independent Power Producers (Utilities), while VRNA operates in Biotechnology (Healthcare). At a 0.08 correlation, their price movements are largely independent.

Performance

OKLO vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oklo Inc. (OKLO) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

OKLO

• 1D: -0.64%
• 1M: -17.47%
• YTD: -19.89%
• 6M: -34.24%
• 1Y: -10.84%
• 3Y*: 75.64%
• 5Y*: —
• 10Y*: —

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

OKLO vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
OKLO Oklo Inc.	-19.89%	238.01%	101.04%	6.45%	0.71%	-1.50%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	18.10%

Correlation

The correlation between OKLO and VRNA is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (All Time) Calculated using the full available price history since Jul 8, 2021	0.08

The correlation between OKLO and VRNA shifts across timeframes, from -0.04 (1 year) to 0.09 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap OKLO : $9.79B VRNA : $9.72B
EPS OKLO : -$0.85 VRNA : -$0.69
PB Ratio OKLO : 3.71 VRNA : 34.92
Total Revenue (TTM) OKLO : $0.00 VRNA : $167.65M
Gross Profit (TTM) OKLO : -$149.00K VRNA : $159.52M
EBITDA (TTM) OKLO : -$172.42M VRNA : -$40.86M

Return for Risk

OKLO vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OKLO

OKLO Risk / Return Rank: 41
OKLO Sharpe Ratio Rank: 39
OKLO Sortino Ratio Rank: 46
OKLO Omega Ratio Rank: 44
OKLO Calmar Ratio Rank: 39
OKLO Martin Ratio Rank: 39

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OKLO vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oklo Inc. (OKLO) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	OKLO	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	-0.11	—	—
Sortino ratio: Return per unit of downside risk	0.60	—	—
Omega ratio: Gain probability vs. loss probability	1.06	—	—
Calmar ratio: Return relative to maximum drawdown	-0.15	—	—
Martin ratio: Return relative to average drawdown	-0.24	—	—

Drawdowns

Drawdown Indicators

	OKLO	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-73.83%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-73.83%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-73.83%	—	—
Current Drawdown Current decline from peak	-66.99%	—	—
Average Drawdown Average peak-to-trough decline	-18.13%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	45.70%	—	—

Volatility

Volatility by Period

	OKLO	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	27.86%	—	—
Volatility (6M) Calculated over the trailing 6-month period	69.66%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	101.88%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	85.88%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.88%	—	—

Dividends

OKLO vs. VRNA - Dividend Comparison

Neither OKLO nor VRNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both OKLO and VRNA in my portfolio?

OKLO and VRNA have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.